AGP Picks
View all

3D cardiac mapping market seen reaching $2.97B by 2030

Oct. 28, 2026
3D cardiac mapping market seen reaching $2.97B by 2030
By AI, Created 16:30 UTC, Oct 28, 2026, AGP -

The 3D cardiac mapping system market is projected to rise to $2.97 billion by 2030, up from $2.07 billion in 2026, as demand grows for arrhythmia diagnosis and precision-guided ablation. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - 3D cardiac mapping systems are central to diagnosing and treating heart rhythm disorders. - The market outlook points to sustained demand from cardiovascular care, minimally invasive procedures and software-driven mapping tools. - Rising global cardiovascular disease rates are expanding the need for more precise electrophysiology procedures.

What happened: - The Business Research Company said the global 3D cardiac mapping system market will grow from $2.07 billion in 2026 to $2.97 billion by 2030. - The forecast implies a 9.4% compound annual growth rate over the period. - The company’s report also estimates the market at $1.89 billion in 2025, rising to $2.07 billion in 2026. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing regional market during the forecast period.

The details: - A 3D cardiac mapping system uses catheters with embedded electrodes inserted into the heart chambers. - The systems create three-dimensional maps of the heart’s electrical activity. - Physicians use those maps to identify abnormal rhythms and guide catheter ablation and other targeted treatments. - Historical growth was supported by rising cardiac arrhythmias, wider use of catheter ablation, higher investment in cardiac healthcare infrastructure, technical improvements in electrophysiology equipment and stronger awareness of early arrhythmia diagnosis. - Forecast growth is expected to come from artificial intelligence-based cardiac mapping algorithms, demand for precision-guided ablation therapies, expansion of ambulatory surgical centers, higher cardiovascular spending and continued advances in mapping software and visualization tools. - The company flagged broader adoption of 3D mapping in complex arrhythmia cases, higher demand for high-resolution cardiac maps, more minimally invasive electrophysiology procedures, better catheter design and electrode density, and growth in electrophysiology labs worldwide. - In January 2024, the British Heart Foundation said about 7.6 million people in the UK live with heart and circulatory diseases. - The British Heart Foundation said those diseases account for about 27% of all deaths in the UK, or more than 170,000 deaths a year.

Between the lines: - The market is being pulled by two forces at once: more patients with cardiovascular disease and better technology to diagnose and treat arrhythmias. - North America's lead likely reflects stronger R&D and faster adoption of advanced medical technology. - Asia-Pacific's growth outlook suggests expanding access to cardiac care and rising spending may create the next major demand center. - The focus on AI and visualization shows the market is shifting from hardware alone to more software-enabled, precision tools.

What's next: - The company expects the market to keep expanding as more hospitals and surgical centers adopt advanced mapping systems. - Product development will likely center on higher-resolution imaging, better catheter performance and AI-supported workflow tools. - The report includes updated graphics, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, and key technology and trend analysis. - More information is available in the full report and a free sample report.

The bottom line: - 3D cardiac mapping is moving from a specialized electrophysiology tool to a core growth market in cardiac care, with AI and precision ablation shaping the next phase.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

UK Herald Tribune

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

UK Herald Tribune

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.